These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1157346)

  • 1. The kinetics of aminosidine in renal patients with different degrees of renal failure.
    Novarini A; Montanari A; Bruschi G; Rossi E; Borghetti A; Migone L
    Clin Nephrol; 1975 Jul; 4(1):23-4. PubMed ID: 1157346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of norfloxacin in chronic renal failure.
    Arrigo G; Cavaliere G; D'Amico G; Passarella E; Broccali G
    Int J Clin Pharmacol Ther Toxicol; 1985 Sep; 23(9):491-6. PubMed ID: 4055162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disposition kinetics of dibekacin in normal subjects and in patients with renal failure.
    Arancibia A; Chávez J; Ibarra R; Ruiz I; Icarte A; Thambo S; Chávez H
    Int J Clin Pharmacol Ther Toxicol; 1987 Jan; 25(1):38-43. PubMed ID: 3557728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacokinetics of cefotaxime and metabolites in uremic patients (author's transl)].
    Fillastre JP; Ings RM; Leroy A; Godin M; Humbert G
    Nephrologie; 1982; 3(1):12-8. PubMed ID: 6283411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacokinetic characteristics of a massive dose of furosemide in acute kidney failure].
    Lucas A; Meignan M; Le Gall JR; Tillement JP; Rapin M
    Biomedicine; 1976 Jan; 24(1):45-9. PubMed ID: 773444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study of practolol elimination in all grades of chronic renal failure.
    Kaye CM; Kumana CR; Franklin DA; Baker LR
    Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):83-8. PubMed ID: 1165145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of ceftriaxone in subjects with renal insufficiency.
    Kowalsky SF; Echols RM; Parker MA
    Clin Pharm; 1985; 4(2):177-81. PubMed ID: 3987216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of ofloxacin in severe chronic renal failure.
    Bandai H; Tsubakihara Y; Yamato E; Yokoyama K; Okada N; Nakanishi I; Iida N
    Clin Ther; 1989; 11(2):210-8. PubMed ID: 2736567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calculation of creatinine clearance from plasma creatinine.
    McLigeyo SO
    East Afr Med J; 1993 Jan; 70(1):3-5. PubMed ID: 8513724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of anakinra in subjects with different levels of renal function.
    Yang BB; Baughman S; Sullivan JT
    Clin Pharmacol Ther; 2003 Jul; 74(1):85-94. PubMed ID: 12844139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of renal function on plasma levels and urinary excretion of acebutolol and its main N-acetyl metabolite.
    Kirch W; Köhler H; Berggren G; Braun W
    Clin Nephrol; 1982 Aug; 18(2):88-94. PubMed ID: 7140021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Differences between the glomerular filtration rate estimated by the MDRD equation and the measurement of creatinine and urea clearance in unselected patients with terminal renal insufficiency].
    Caravaca F; Arrobas M; Luna E; Naranjo M; Pizarro JL; Sánchez-Casado E
    Nefrologia; 2002; 22(5):432-7. PubMed ID: 12497744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doses of antibiotic in patients with renal insufficiency.
    Ohkawa M; Kuroda K
    Clin Ther; 1981; 4 Suppl A():124-32. PubMed ID: 6275994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and dosage reduction of cis-diammine(1,1-cyclobutanedicarboxylato)platinum in patients with impaired renal function.
    Egorin MJ; Van Echo DA; Tipping SJ; Olman EA; Whitacre MY; Thompson BW; Aisner J
    Cancer Res; 1984 Nov; 44(11):5432-8. PubMed ID: 6386150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of lenalidomide in subjects with various degrees of renal impairment and in subjects on hemodialysis.
    Chen N; Lau H; Kong L; Kumar G; Zeldis JB; Knight R; Laskin OL
    J Clin Pharmacol; 2007 Dec; 47(12):1466-75. PubMed ID: 17954615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Renal clearance of hippurate in persons with chronic renal insufficiency].
    Schück O; Spustová V; Dzúrik R; Teplan V; Nádvorníková H; Skibová J
    Vnitr Lek; 1994 Jul; 40(7):407-10. PubMed ID: 8073654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacokinetics of cefotaxime in patients with chronic renal impairment (author's transl)].
    Fillastre JP; Ings RM; Leroy A; Humbert G; Godin M
    Nouv Presse Med; 1981 Feb; 10(8):574-9. PubMed ID: 6259595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Butofilolol pharmacokinetics in chronic renal insufficiency.
    Jeanniot JP; Houin G; Ledudal P; Cautreels W; Giudicelli CP; Tillement JP
    Int J Clin Pharmacol Res; 1984; 4(3):165-73. PubMed ID: 6149194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of amoxicillin in subjects with normal and impaired renal function.
    Arancibia A; Drouguett MT; Fuentes G; González G; González C; Thambo S; Palombo G
    Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):447-53. PubMed ID: 7141752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and optimum dose of disopyramide in patients with chronic renal failure.
    Nagura Y; Kuno T; Yanai M; Maejima M; Okada K; Maeda H; Inoue M; Takahashi S; Hatano M
    Nihon Jinzo Gakkai Shi; 1991 May; 33(5):539-43. PubMed ID: 1895553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.